title: Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
authors.forename: G
authors.initials: G
authors.lastname: Tonini
authors.forename: C
authors.initials: C
authors.lastname: Bizzarri
authors.forename: R
authors.initials: R
authors.lastname: Bonfanti
authors.forename: M
authors.initials: M
authors.lastname: Vanelli
authors.forename: F
authors.initials: F
authors.lastname: Cerutti
authors.forename: E
authors.initials: E
authors.lastname: Faleschini
authors.forename: F
authors.initials: F
authors.lastname: Meschi
authors.forename: F
authors.initials: F
authors.lastname: Prisco
authors.forename: E
authors.initials: E
authors.lastname: Ciacco
authors.forename: M
authors.initials: M
authors.lastname: Cappa
authors.forename: C
authors.initials: C
authors.lastname: Torelli
authors.forename: V
authors.initials: V
authors.lastname: Cauvin
authors.forename: S
authors.initials: S
authors.lastname: Tumini
authors.forename: D
authors.initials: D
authors.lastname: Iafusco
authors.forename: F
authors.initials: F
authors.lastname: Barbetti
mesh_terms: D019943:Amino Acid Substitution; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D007328:Insulin / Q000627:therapeutic use*; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds